Tag: Imfinzi bladder cancer patient outcomes

Imfinzi, an immunotherapy developed by AstraZeneca, has shown promising results in improving survival rates for patients with bladder cancer. The study, which involved administering Imfinzi both before and after surgery, has the potential to...